Inventor · disambiguated record
Shuling Guo
Also filed as: GUO SHULING
13 granted patents·16 pending applications·69 citations·filing 2007–2023
91Inventor score
Files withIONIS PHARMACEUTICALS INC26ISIS PHARMACEUTICALS INC1UCLA Office of Intellectual Property1UNIV CALIFORNIA1
Top patents by PatentIndex Score
29 records- 0196US8697860B1Diagnosis and treatment of diseaseISIS PHARMACEUTICALS INC·Filed 2013·Granted Apr 15, 2014·25 cites·16 claims
- 0295US9399774B2Modulation of transthyretin expressionIONIS PHARMACEUTICALS INC·Filed 2015·Granted Jul 26, 2016·13 cites·40 claims
- 0394US9340784B2Methods and compositions for modulating alpha-1-antitrypsin expressionIONIS PHARMACEUTICALS INC·Filed 2013·Granted May 17, 2016·11 cites·14 claims
- 0492US9816092B2Modulation of transthyretin expressionIONIS PHARMACEUTICALS INC·Filed 2016·Granted Nov 14, 2017·7 cites·8 claims
- 0590US9796976B2Methods and compositions for modulating alpha-1 antitrypsin expressionIONIS PHARMACEUTICALS INC·Filed 2016·Granted Oct 24, 2017·3 cites·18 claims
- 0689US10415038B2Compounds and methods for modulating TMPRSS6 expressionIONIS PHARMACEUTICALS INC·Filed 2016·Granted Sep 17, 2019·5 cites·29 claims
- 0786US11535849B2Modulation of transthyretin expressionIONIS PHARMACEUTICALS INC·Filed 2020·Granted Dec 27, 2022·1 cites·10 claims
- 0881US2023212564A1Methods and compositions for modulating alpha-1-antitrypsin expressionIONIS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0981US2024026364A1Compounds and methods for modulating tmprss6 expressionIONIS PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1080US9885047B2Modulation of TMPRSS6 expressionIONIS PHARMACEUTICALS INC·Filed 2016·Granted Feb 6, 2018·1 cites·33 claims
- 1177US10577607B2Modulation of DYRK1B expressionIONIS PHARMACEUTICALS INC·Filed 2017·Granted Mar 3, 2020·1 cites·13 claims
- 1277US9725722B2Modulation of TMPRSS6 expressionIONIS PHARMACEUTICALS INC·Filed 2012·Granted Aug 8, 2017·1 cites·29 claims
- 1377US2024327838A1MODULATORS OF ENaC EXPRESSIONIONIS PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1474US2020157535A1Methods and compositions for modulating alpha-1-antitrypsin expressionIONIS PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1574US2022073913A1Methods and compositions for modulating alpha-1-antitrypsin expressionIONIS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1672US2022259600A1Compounds and methods for modulating tmprss6 expressionIONIS PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1770US9714288B2Antisense compounds and uses thereofUNIV CALIFORNIA·Filed 2015·Granted Jul 25, 2017·1 cites·16 claims
- 1869US2019169613A1Modulation of transthyretin expressionIONIS PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 1969US2018230465A1Methods and compositions for modulating alpha-1-antitrypsin expressionIONIS PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 2068US10184125B2Modulation of TMPRSS6 expressionIONIS PHARMACEUTICALS INC·Filed 2017·Granted Jan 22, 2019·0 cites·20 claims
- 2168US2020190522A1Compounds and methods for modulating tmprss6 expressionIONIS PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 2268US2019338288A1Modulation of tmprss6 expressionIONIS PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2367US2022290137A1Compounds and methods for reducing spdef expressionIONIS PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2465US2018273946A1Modulation of transthyretin expressionIONIS PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 2562US2021139906A1Compounds and methods for reducing spdef expressionIONIS PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2660US2024294920A1Modulation of nox4 expressionIONIS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2755US2021180057A1MODULATORS OF ENaC EXPRESSIONIONIS PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2848US2011129850A1Microfluidic platform for cell culture and assayUCLA Office of Intellectual Property·Filed 2007·Application pending·0 cites
- 2943US10287584B2Compounds and methods for the modulation of COMPIONIS PHARMACEUTICALS INC·Filed 2015·Granted May 14, 2019·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Shuling Guo files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →